23 Feb Century Therapeutics
Gregory Russotti, Ph.D., Chief Technology Officer
Century Therapeutics is harnessing the power of stem cells to develop curative cell therapy products for cancer that overcome the limitations of first generation cell therapies. Our genetically engineered, universal iPSC-derived immune effector cell products (NK and T-cells) are designed to specifically target hematologic and solid tumor cancers. Our commitment to developing off-the-shelf cell therapies will expand patient access and provide an unparalleled opportunity to advance the course of cancer care. Century was launched in 2019 by founding investor Versant Ventures in partnership with Fujifilm and Leaps by Bayer.